You are currently viewing a new version of our website. To view the old version click .
Non-Coding RNA
  • Correction
  • Open Access

16 May 2025

Correction: Schlösser et al. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells. Non-Coding RNA 2025, 11, 8

,
,
,
,
,
,
,
,
and
1
Institute of Pharmaceutical Sciences, ETH Zurich, 8093 Zurich, Switzerland
2
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
3
Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland
4
Max Planck Institute of Molecular Physiology, Chemical Genomics Centre, 44227 Dortmund, Germany
Seyedeh Elnaz Banijamali was not included as an author in the original publication [1]. The corrected Author Contributions statement appears here: Seyedeh Elnaz Banijamali executed experiments and analyzed data related to the SHAPE-MaP assay and read and approved the final manuscript.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Schlösser, V.; Lightfoot, H.L.; Leemann, C.; Banijamali, S.E.; Bejoy, A.M.; Tiwari, S.; Schloßhauer, J.L.; Vongrad, V.; Brunschweiger, A.; Hall, J.; et al. Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells. Non-Coding RNA 2025, 11, 8. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.